Current Neuropace forecasts and price targets in August 2026
Ø Analyst Price Targets
19.89 USD
+43.09 %
Median
20.40 USD
+46.76 %
Max
23.10 USD
Min
15.15 USD
Last Price
13.90 USD
Buy
13
Hold
1
Sell
0
The average target price for Neuropace is 19.89 USD. (+43.09 % above the current price)
The median price target of Neuropace is 20.40 USD.
Stock analysts from many renowned investment banks are closely examining the Neuropace stock. They conclude their professional Neuropace stock analyses with a clear recommendation for the Neuropace stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 13 | 1 | 0 | 19.89 USD |
| 2026-01-01 | 13 | 1 | 0 | 19.64 USD |
| 2025-12-01 | 13 | 1 | 0 | 19.00 USD |
| 2025-12-01 | 13 | 1 | 0 | 17.85 USD |
| 2025-11-01 | 13 | 1 | 0 | 17.85 USD |
| 2025-11-01 | 13 | 1 | 0 | 17.19 USD |
Neuropace Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Neuropace in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 99.00 M USD | -21.00 M USD | -0.64 USD |
| 2027e | 123.00 M USD | -12.00 M USD | -0.37 USD |
| 2028e | 153.00 M USD | -7.00 M USD | -0.21 USD |